Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
"You underestimate my pow-waaaaahh [of turning things into an issue]!!!"
... but I do appreciate the reassurance - thanks. :)
On another note: I'm so glad this happened now and not (late) last year - I really didn't want to have to deal with this come tax time this year. Happy to be able to punt that to 2022.
Someone else shared this one earlier:
https://www.nasdaq.com/market-activity/stocks/lexx/real-time
Claims it's real-time, anyway. XD
Couldn't agree with you more.
My fingers are tightly crossed as well.
Perhaps... But if you don't address the fundamental problem, you're constantly trying to build atop sand.
Put another way: If you can't keep-up with your mortgage payments because your beat-up Buick keeps breaking down, it may - and I say "may" - very well be time to take-out another mortgage and get that new Tesla so you may have a fighting chance to improve your fundamental circumstances. (I.e., now you can get to where you need to go, to do what you need to do, to be able to start paying those bills.)
Of course, if you use that second mortgage on that new wo/man cave you've always wanted instead, then IMHO you sort of deserve where that'll invariably lead you.
Say what you will about Bunka; but "liquidity FTW."
The OTC was like wading through quicksand for Lexaria.
Thanks for sharing.
Yeah - I can believe they're going to announce "at least half a dozen more studies in the next six months"... Heck, I could believe it if they were going to announce "at least two dozen more studies in the next six months" - they don't seem to do / announce much else...! :D
XD
Someone didn't like what was in their breakfast cereal this morning...! ;D
Peter Gibbons: You're gonna lay off Samir and Michael?
Bob Slydell: Oh yeah, we're bring in some entry-level graduates, farm some work out to Singapore, that's the usual deal.
Bob Porter: Standard operating procedure.
Peter Gibbons: Do they know this yet?
Bob Slydell: No. No, of course not. We find it's always better to fire people on a Friday. Studies have statistically shown that there's less chance of an incident if you do it at the end of the week.
Free publicity!
Ooh nooo not good news...!
Now we can expect PPS to drop to 0.15USD today. XD
All I'm reading is: "Expect absolutely no catalysts - i.e., nothing to change the bottom-dollar PPS - between now and Christmas."
Take 'er easy...
I'm in the same/similar boat - been gradually backing-off because I've just let myself get too wrapped-up in something that, in the balance, isn't all that important to me. Plus, I have faith it'll prosper eventually, and I'm willing to wait - I don't need to know what's going on day-to-day.
Peace!
I'm already getting the impression that identifying BTI by name in such PRs isn't going to be the "big hush-hush no-no" Altria had clearly made it.
I hate to say this, but, what is it then that they're going to go to the "big institutional investors" with... this!?
How about a 1-minute Proactive Investors "nothing new here" article instead...? XD
https://www.proactiveinvestors.com/companies/news/931218/lexaria-bioscience-updates-on-business-relationship-with-altria-ventures-931218.html
This line of thinking is what I was trying to get at earlier in the day - i.e., passing on phase II/III does not necessarily mean they don't like the tech; it could mean they no longer like this particular deal.
They'd have those - and more - if they just bought the division.
Not that I'm outright disagreeing with you - $4M is nothing for what they'd be locking down - but I'm just pointing-out that Altria might choose to pursue a different "contract" - and that's one reason they may "pass" on this one; that's all.